| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $566K | +44.5% |
| R&D Expense | $36.8M | +28.6% |
| SG&A Expense | $25.7M | -17.4% |
| Operating Income | -$61.9M | -4.4% |
| Pre-tax Income | -$26.4M | +49.5% |
| Income Tax | $0 | — |
| Net Income | -$26.4M | +49.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.3M | -2.7% |
| Current Assets | $55.9M | -49.0% |
| Total Assets | $92.2M | -36.0% |
| Current Liabilities | $10.5M | -8.3% |
| Total Liabilities | $23.9M | -57.4% |
| Stockholders' Equity | $68.2M | -22.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.0M | -22.2% |
| Capital Expenditures | $71K | +76.1% |
| Investing Cash Flow | $54.6M | +2215.6% |
| Financing Cash Flow | $622K | -98.0% |
| Free Cash Flow | -$56.0M | -22.3% |